explore -WSS

explore

author：knowledge 2025-10-01 00:06:46 - browse：41

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Astronauts get first look at the spacecraft that will fly them around the moon

WSS

Biden praises World Series champion Astros for impact off the field during White House celebration

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Congress needs to close a vaccine

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

Choosing scientific sides in the fight against Alzheimer's

Illumina board agrees to spin off Grail, as divestment plans proceed

hotspot

explore

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

Astronauts get first look at the spacecraft that will fly them around the moon

In Memoriam: Notable people who died in 2023

Take antibiotics after sex, CDC recommends for certain risk groups

At least 13 dead in Texas as scorching temps continue

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Activists slam private health insurers over coverage restrictions

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Medicare details structure of new drug price negotiation program

In venture capital firm's success, lessons for turning crisis into profit

hotspot

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Stopping antidepressants leads to symptoms for 1 in 6 patients

Judge rejects Trump's counterclaim against E. Jean Carroll

More regulation could be coming for drug ads

Lessons Learned: This is why you network to find that industry job you want

FTC loses bid to block Novant's North Carolina hospital merger

entertainment

hotspot

focus

leisure time